TaiMed Biologics Inc. (TPEX: 4147)
Taiwan
· Delayed Price · Currency is TWD 79.90
-0.70 (-0.87%)
Sep 10, 2024, 1:30 PM CST
TaiMed Biologics Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 9, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 21,813 | 20,746 | 17,843 | 17,813 | 21,212 | 24,991 | Upgrade
|
| Market Cap Growth | -8.97% | 16.27% | 0.17% | -16.02% | -15.12% | -39.85% | Upgrade
|
| Enterprise Value | 20,206 | 20,859 | 17,860 | 17,487 | 20,408 | 23,356 | Upgrade
|
| Last Close Price | 79.90 | 80.83 | 69.69 | 69.59 | 82.90 | 97.68 | Upgrade
|
| PE Ratio | - | -104.90 | -65.13 | -37.21 | -113.56 | -42.47 | Upgrade
|
| PS Ratio | 32.14 | 42.19 | 31.69 | 43.09 | 29.36 | 35.47 | Upgrade
|
| PB Ratio | 5.21 | 8.08 | 6.57 | 6.06 | 6.21 | 6.97 | Upgrade
|
| P/FCF Ratio | 188.86 | -653.35 | -29.31 | -80.62 | -83.00 | -32.17 | Upgrade
|
| P/OCF Ratio | 203.37 | -810.35 | -29.48 | -84.31 | -105.04 | -38.14 | Upgrade
|
| EV/Sales Ratio | 31.49 | 42.42 | 31.72 | 42.30 | 28.25 | 33.15 | Upgrade
|
| EV/EBITDA Ratio | 573.42 | -1177.34 | -423.06 | -52.00 | 8869.02 | -77.75 | Upgrade
|
| EV/EBIT Ratio | -211.02 | -125.48 | -93.09 | -35.95 | -153.72 | -59.89 | Upgrade
|
| EV/FCF Ratio | 174.94 | -656.91 | -29.34 | -79.14 | -79.86 | -30.07 | Upgrade
|
| Debt / Equity Ratio | 0.13 | 0.29 | 0.28 | 0.19 | 0.17 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 12.78 | - | - | - | 130.59 | - | Upgrade
|
| Debt / FCF Ratio | 4.65 | -23.65 | -1.26 | -2.57 | -2.23 | -0.04 | Upgrade
|
| Asset Turnover | 0.14 | 0.12 | 0.13 | 0.08 | 0.15 | 0.15 | Upgrade
|
| Inventory Turnover | 0.29 | 0.20 | 0.27 | 0.27 | 0.29 | 0.76 | Upgrade
|
| Quick Ratio | 16.56 | 2.31 | 2.32 | 5.12 | 3.23 | 3.51 | Upgrade
|
| Current Ratio | 25.38 | 5.96 | 6.56 | 10.37 | 6.02 | 5.74 | Upgrade
|
| Return on Equity (ROE) | -3.21% | -7.38% | -9.52% | -14.82% | -5.24% | -15.09% | Upgrade
|
| Return on Assets (ROA) | -1.46% | -2.60% | -2.75% | -6.20% | -1.67% | -5.12% | Upgrade
|
| Return on Capital (ROIC) | -1.66% | -3.06% | -3.43% | -8.11% | -2.18% | -6.33% | Upgrade
|
| Earnings Yield | -0.54% | -0.94% | -1.51% | -2.64% | -0.86% | -2.32% | Upgrade
|
| FCF Yield | 0.53% | -0.15% | -3.41% | -1.24% | -1.20% | -3.11% | Upgrade
|
| Buyback Yield / Dilution | -2.22% | -0.18% | -0.04% | -0.03% | -0.07% | -0.52% | Upgrade
|
| Total Shareholder Return | -2.22% | -0.18% | -0.04% | -0.03% | -0.07% | -0.52% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.